Is adalimumab protective in ischemia-reperfusion injury in lung?

OBJECTIVE(S): Increasing cytokines and reactive oxygen species (ROS) during ischemia reperfusion (I-R) leads to the lung damage. Adalimumab (Ada) is a potent tumor necrosis factor-alpha (TNF-α) inhibitor agent. We aimed to evaluate whether Ada would prevent the lung tissue from damage development ov...

Full description

Saved in:
Bibliographic Details
Published in:Iran J Basic Med Sci
Main Authors: Kurt, Aysel, Tumkaya, Levent, Kalkan, Yildiray, Turut, Hasan, Cure, Medine Cumhur, Cure, Erkan, Sehitoglu, Ibrahim, Bilgin, Hacer, Usta, Mustafa
Format: Artigo
Language:Inglês
Published: Mashhad University of Medical Sciences 2015
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4764110/
https://ncbi.nlm.nih.gov/pubmed/26949496
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items